 | • レポートコード：GIR-105X14215 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組換え型ヒトインスリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型ヒトインスリンの種類別市場規模（）、用途別市場規模（1型糖尿病、2型糖尿病）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型ヒトインスリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Akron Biotech、Wockhardt、Dance Biopharm、Novo Nordisk、Gan & Lee、United Laboratories、Dongbro Pharmaceuticri ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年： ・用途別分析2016年-2026年：1型糖尿病、2型糖尿病 ・遺伝子組換え型ヒトインスリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型ヒトインスリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型ヒトインスリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型ヒトインスリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型ヒトインスリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Human Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Human Insulin size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Human Insulin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Human Insulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Market segment by Application can be divided into
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
The key market players for global Recombinant Human Insulin market are listed below:
Akron Biotech
Wockhardt
Dance Biopharm
Novo Nordisk
Gan & Lee
United Laboratories
Dongbro Pharmaceuticri
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Recombinant Human Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Human Insulin Revenue by Type: 2019 Versus 2021 Versus 2026
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Human Insulin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Type 1 Diabetes Mellitus
1.3.3 Type 2 Diabetes Mellitus
1.4 Global Recombinant Human Insulin Market Size & Forecast
1.4.1 Global Recombinant Human Insulin Sales in Value (2016-2026))
1.4.2 Global Recombinant Human Insulin Sales in Volume (2016-2026)
1.4.3 Global Recombinant Human Insulin Price by Type (2016-2026) & (USD/mg)
1.5 Global Recombinant Human Insulin Production Capacity Analysis
1.5.1 Global Recombinant Human Insulin Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Human Insulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Human Insulin Market Drivers
1.6.2 Recombinant Human Insulin Market Restraints
1.6.3 Recombinant Human Insulin Trends Analysis
2 Manufacturers Profiles
2.1 Akron Biotech
2.1.1 Akron Biotech Details
2.1.2 Akron Biotech Major Business
2.1.3 Akron Biotech Recombinant Human Insulin Product and Services
2.1.4 Akron Biotech Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Wockhardt
2.2.1 Wockhardt Details
2.2.2 Wockhardt Major Business
2.2.3 Wockhardt Recombinant Human Insulin Product and Services
2.2.4 Wockhardt Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Dance Biopharm
2.3.1 Dance Biopharm Details
2.3.2 Dance Biopharm Major Business
2.3.3 Dance Biopharm Recombinant Human Insulin Product and Services
2.3.4 Dance Biopharm Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Recombinant Human Insulin Product and Services
2.4.4 Novo Nordisk Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Gan & Lee
2.5.1 Gan & Lee Details
2.5.2 Gan & Lee Major Business
2.5.3 Gan & Lee Recombinant Human Insulin Product and Services
2.5.4 Gan & Lee Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 United Laboratories
2.6.1 United Laboratories Details
2.6.2 United Laboratories Major Business
2.6.3 United Laboratories Recombinant Human Insulin Product and Services
2.6.4 United Laboratories Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Dongbro Pharmaceuticri
2.7.1 Dongbro Pharmaceuticri Details
2.7.2 Dongbro Pharmaceuticri Major Business
2.7.3 Dongbro Pharmaceuticri Recombinant Human Insulin Product and Services
2.7.4 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Human Insulin Sales by Manufacturer
3.1 Global Recombinant Human Insulin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Human Insulin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Human Insulin
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Human Insulin Manufacturer Market Share
3.4.2 Top 6 Recombinant Human Insulin Manufacturer Market Share
3.5 Global Recombinant Human Insulin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Human Insulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Human Insulin Market Size by Region
4.1.1 Global Recombinant Human Insulin Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Human Insulin Revenue by Region (2016-2026)
4.2 North America Recombinant Human Insulin Revenue (2016-2026)
4.3 Europe Recombinant Human Insulin Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Human Insulin Revenue (2016-2026)
4.5 South America Recombinant Human Insulin Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Human Insulin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Human Insulin Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Human Insulin Revenue by Type (2016-2026)
5.3 Global Recombinant Human Insulin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Human Insulin Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Human Insulin Revenue by Application (2016-2026)
6.3 Global Recombinant Human Insulin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Human Insulin Sales by Type (2016-2026)
7.2 North America Recombinant Human Insulin Sales by Application (2016-2026)
7.3 North America Recombinant Human Insulin Market Size by Country
7.3.1 North America Recombinant Human Insulin Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Human Insulin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Human Insulin Sales by Type (2016-2026)
8.2 Europe Recombinant Human Insulin Sales by Application (2016-2026)
8.3 Europe Recombinant Human Insulin Market Size by Country
8.3.1 Europe Recombinant Human Insulin Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Human Insulin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Human Insulin Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Human Insulin Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Human Insulin Market Size by Region
9.3.1 Asia-Pacific Recombinant Human Insulin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Human Insulin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Human Insulin Sales by Type (2016-2026)
10.2 South America Recombinant Human Insulin Sales by Application (2016-2026)
10.3 South America Recombinant Human Insulin Market Size by Country
10.3.1 South America Recombinant Human Insulin Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Human Insulin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Human Insulin Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Human Insulin Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Human Insulin Market Size by Country
11.3.1 Middle East & Africa Recombinant Human Insulin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Human Insulin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Human Insulin Typical Distributors
12.3 Recombinant Human Insulin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Human Insulin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Human Insulin Revenue by Application, (USD Million), 2021-2026
Table 3. Akron Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Akron Biotech Major Business
Table 5. Akron Biotech Recombinant Human Insulin Product and Services
Table 6. Akron Biotech Recombinant Human Insulin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 8. Wockhardt Major Business
Table 9. Wockhardt Recombinant Human Insulin Product and Services
Table 10. Wockhardt Recombinant Human Insulin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Dance Biopharm Basic Information, Manufacturing Base and Competitors
Table 12. Dance Biopharm Major Business
Table 13. Dance Biopharm Recombinant Human Insulin Product and Services
Table 14. Dance Biopharm Recombinant Human Insulin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 16. Novo Nordisk Major Business
Table 17. Novo Nordisk Recombinant Human Insulin Product and Services
Table 18. Novo Nordisk Recombinant Human Insulin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Gan & Lee Basic Information, Manufacturing Base and Competitors
Table 20. Gan & Lee Major Business
Table 21. Gan & Lee Recombinant Human Insulin Product and Services
Table 22. Gan & Lee Recombinant Human Insulin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. United Laboratories Major Business
Table 25. United Laboratories Recombinant Human Insulin Product and Services
Table 26. United Laboratories Recombinant Human Insulin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dongbro Pharmaceuticri Basic Information, Manufacturing Base and Competitors
Table 28. Dongbro Pharmaceuticri Major Business
Table 29. Dongbro Pharmaceuticri Recombinant Human Insulin Product and Services
Table 30. Dongbro Pharmaceuticri Recombinant Human Insulin Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Recombinant Human Insulin Sales by Manufacturer (2019-2021e) & (g)
Table 32. Global Recombinant Human Insulin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Recombinant Human Insulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Recombinant Human Insulin Production Capacity by Company, (g): 2020 VS 2021
Table 35. Head Office and Recombinant Human Insulin Production Site of Key Manufacturer
Table 36. Global Recombinant Human Insulin Sales by Region (2016-2021e) & (g)
Table 37. Global Recombinant Human Insulin Sales by Region (2021-2026) & (g)
Table 38. Global Recombinant Human Insulin Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Recombinant Human Insulin Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Recombinant Human Insulin Sales by Type (2016-2021e) & (g)
Table 41. Global Recombinant Human Insulin Sales by Type (2021-2026) & (g)
Table 42. Global Recombinant Human Insulin Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Recombinant Human Insulin Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Recombinant Human Insulin Price by Type (2016-2021e) & (USD/mg)
Table 45. Global Recombinant Human Insulin Price by Type (2021-2026) & (USD/mg)
Table 46. Global Recombinant Human Insulin Sales by Application (2016-2021e) & (g)
Table 47. Global Recombinant Human Insulin Sales by Application (2021-2026) & (g)
Table 48. Global Recombinant Human Insulin Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Recombinant Human Insulin Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Recombinant Human Insulin Price by Application (2016-2021e) & (USD/mg)
Table 51. Global Recombinant Human Insulin Price by Application (2021-2026) & (USD/mg)
Table 52. North America Recombinant Human Insulin Sales by Country (2016-2021e) & (g)
Table 53. North America Recombinant Human Insulin Sales by Country (2021-2026) & (g)
Table 54. North America Recombinant Human Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Recombinant Human Insulin Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Recombinant Human Insulin Sales by Type (2016-2021e) & (g)
Table 57. North America Recombinant Human Insulin Sales by Type (2021-2026) & (g)
Table 58. North America Recombinant Human Insulin Sales by Application (2016-2021e) & (g)
Table 59. North America Recombinant Human Insulin Sales by Application (2021-2026) & (g)
Table 60. Europe Recombinant Human Insulin Sales by Country (2016-2021e) & (g)
Table 61. Europe Recombinant Human Insulin Sales by Country (2021-2026) & (g)
Table 62. Europe Recombinant Human Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Recombinant Human Insulin Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Recombinant Human Insulin Sales by Type (2016-2021e) & (g)
Table 65. Europe Recombinant Human Insulin Sales by Type (2021-2026) & (g)
Table 66. Europe Recombinant Human Insulin Sales by Application (2016-2021e) & (g)
Table 67. Europe Recombinant Human Insulin Sales by Application (2021-2026) & (g)
Table 68. Asia-Pacific Recombinant Human Insulin Sales by Region (2016-2021e) & (g)
Table 69. Asia-Pacific Recombinant Human Insulin Sales by Region (2021-2026) & (g)
Table 70. Asia-Pacific Recombinant Human Insulin Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Recombinant Human Insulin Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Recombinant Human Insulin Sales by Type (2016-2021e) & (g)
Table 73. Asia-Pacific Recombinant Human Insulin Sales by Type (2021-2026) & (g)
Table 74. Asia-Pacific Recombinant Human Insulin Sales by Application (2016-2021e) & (g)
Table 75. Asia-Pacific Recombinant Human Insulin Sales by Application (2021-2026) & (g)
Table 76. South America Recombinant Human Insulin Sales by Country (2016-2021e) & (g)
Table 77. South America Recombinant Human Insulin Sales by Country (2021-2026) & (g)
Table 78. South America Recombinant Human Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Recombinant Human Insulin Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Recombinant Human Insulin Sales by Type (2016-2021e) & (g)
Table 81. South America Recombinant Human Insulin Sales by Type (2021-2026) & (g)
Table 82. South America Recombinant Human Insulin Sales by Application (2016-2021e) & (g)
Table 83. South America Recombinant Human Insulin Sales by Application (2021-2026) & (g)
Table 84. Middle East & Africa Recombinant Human Insulin Sales by Country (2016-2021e) & (g)
Table 85. Middle East & Africa Recombinant Human Insulin Sales by Country (2021-2026) & (g)
Table 86. Middle East & Africa Recombinant Human Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Recombinant Human Insulin Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Recombinant Human Insulin Sales by Type (2016-2021e) & (g)
Table 89. Middle East & Africa Recombinant Human Insulin Sales by Type (2021-2026) & (g)
Table 90. Middle East & Africa Recombinant Human Insulin Sales by Application (2016-2021e) & (g)
Table 91. Middle East & Africa Recombinant Human Insulin Sales by Application (2021-2026) & (g)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Recombinant Human Insulin Typical Distributors
Table 95. Recombinant Human Insulin Typical Customers
List of Figures
Figure 1. Recombinant Human Insulin Picture
Figure 2. Global Recombinant Human Insulin Sales Market Share by Type in 2020
Figure 3. Global Recombinant Human Insulin Sales Market Share by Application in 2020
Figure 4. Type 1 Diabetes Mellitus
Figure 5. Type 2 Diabetes Mellitus
Figure 6. Global Recombinant Human Insulin Market Size, (USD Million) & (g): 2020 VS 2021 VS 2026
Figure 7. Global Recombinant Human Insulin Market Size and Forecast (2016-2026) & (USD Million)
Figure 8. United States Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 9. Canada Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 10. Mexico Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Germany Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. France Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. United Kingdom Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Russia Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Italy Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. China Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Japan Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Korea Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. India Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Southeast Asia Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Australia Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Brazil Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Egypt Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Saudi Arabia Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. South Africa Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Turkey Recombinant Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Global Recombinant Human Insulin Sales (2016-2026) & (g)
Figure 28. Global Recombinant Human Insulin Production Capacity (2016-2026) & (g)
Figure 29. Global Recombinant Human Insulin Production Capacity by Geographic Region: 2020 VS 2021
Figure 30. Recombinant Human Insulin Market Drivers
Figure 31. Recombinant Human Insulin Market Restraints
Figure 32. Recombinant Human Insulin Market Trends
Figure 33. Global Recombinant Human Insulin Sales Market Share by Manufacturer in 2020
Figure 34. Global Recombinant Human Insulin Revenue Market Share by Manufacturer in 2020
Figure 35. Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 36. Top 3 Recombinant Human Insulin Manufacturer (Revenue) Market Share in 2020
Figure 37. Top 6 Recombinant Human Insulin Manufacturer (Revenue) Market Share in 2020
Figure 38. Global Recombinant Human Insulin Sales Market Share by Region (2016-2026)
Figure 39. Global Recombinant Human Insulin Revenue Market Share by Region (2016-2026)
Figure 40. North America Recombinant Human Insulin Revenue (2016-2026) & (USD Million)
Figure 41. Europe Recombinant Human Insulin Revenue (2016-2026) & (USD Million)
Figure 42. Asia-Pacific Recombinant Human Insulin Revenue (2016-2026) & (USD Million)
Figure 43. South America Recombinant Human Insulin Revenue (2016-2026) & (USD Million)
Figure 44. Middle East & Africa Recombinant Human Insulin Revenue (2016-2026) & (USD Million)
Figure 45. Global Recombinant Human Insulin Sales Market Share by Type (2016-2026)
Figure 46. Global Recombinant Human Insulin Revenue Market Share by Type (2016-2026)
Figure 47. Global Recombinant Human Insulin Price by Type (2016-2026) & (USD/mg)
Figure 48. Global Recombinant Human Insulin Sales Market Share by Application (2016-2026)
Figure 49. Global Recombinant Human Insulin Revenue Market Share by Application (2016-2026)
Figure 50. Global Recombinant Human Insulin Price by Application (2016-2026) & (USD/mg)
Figure 51. North America Recombinant Human Insulin Sales Market Share by Country (2016-2026)
Figure 52. North America Recombinant Human Insulin Revenue Market Share by Country (2016-2026)
Figure 53. North America Recombinant Human Insulin Sales Market Share by Type (2016-2026)
Figure 54. North America Recombinant Human Insulin Sales Market Share by Application (2016-2026)
Figure 55. Europe Recombinant Human Insulin Sales Market Share by Country (2016-2026)
Figure 56. Europe Recombinant Human Insulin Revenue Market Share by Country (2016-2026)
Figure 57. Europe Recombinant Human Insulin Sales Market Share by Type (2016-2026)
Figure 58. Europe Recombinant Human Insulin Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Recombinant Human Insulin Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Recombinant Human Insulin Revenue Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Recombinant Human Insulin Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Recombinant Human Insulin Sales Market Share by Application (2016-2026)
Figure 63. South America Recombinant Human Insulin Sales Market Share by Country (2016-2026)
Figure 64. South America Recombinant Human Insulin Revenue Market Share by Country (2016-2026)
Figure 65. South America Recombinant Human Insulin Sales Market Share by Type (2016-2026)
Figure 66. South America Recombinant Human Insulin Sales Market Share by Application (2016-2026)
Figure 67. Middle East & Africa Recombinant Human Insulin Sales Market Share by Country (2016-2026)
Figure 68. Middle East & Africa Recombinant Human Insulin Revenue Market Share by Country (2016-2026)
Figure 69. Middle East & Africa Recombinant Human Insulin Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Recombinant Human Insulin Sales Market Share by Application (2016-2026)
Figure 71. Sales Channel: Direct Channel vs Indirect Channel
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界の人間インスリンデリバリーシステム市場 2021：企業別、地域別、種類・用途別 The Human Insulin Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…- 世界の遺伝子組換え型ヒト卵胞刺激ホルモン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Follitropin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の遺伝子組換え型ヒトトロンボポエチン（rhTPO）市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Thrombopoietin (rhTPO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の遺伝子組換え型ヒトインターロイキン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Interleukin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の遺伝子組換え型ヒトインターフェロン市場 2021：企業別、地域別、種類・用途別 The Recombinant Human Interferon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…